Asia-Pacific Is Expected to Grow at The Highest Rate in The Coming Years in Immunoassay Instruments Market

The immunoassay instruments market is growing with a considerable rate due to rising incidence of chronic infectious diseases, increasing preference for personalized medicine, and technological advancements. Investments in emerging economies, and focus on developing compact, reliable and portable immunoassay instruments are some of the factors giving ample opportunities to the immunoassay instruments market to grow in the coming years.


Immunoassay is a laboratory based diagnostic procedure that is performed using an immunological reaction of antibodies. The formation of antibody antigen complexes in blood samples and other body fluids are measured by immunoassay instruments and are usually engaged to detect analytes in quantitative or qualitative manner. Qualitative analyses of immunoassay test include immunoassay tests by detecting human chorionic gonadotropin in urine samples for pregnancy. Immunoassay is done in multiple steps with reagents being added and washed away at different points during the assay.


The immunoassay instruments market can be categorized on the basis of applications as oncology, endocrinology, autoimmune disorders, bone and mineral disorders, allergy, infectious diseases, neonatal screening, hematology, blood screening, cardiology, stool testing, and toxicology. On the basis of end users, the immunoassay instruments market can be categorized as laboratories, pharmaceutical companies, academic research centers, hospitals, patient self testing, biotechnology companies, ambulatory centers, blood banks, and physician’s offices.


North America dominates the immunoassay instruments market due to expanding biotechnology and pharmaceutical industries, rising incidences of chronic diseases, government support and the launch of new products in the region. Asia-Pacific is expected to grow at the highest rate in the coming years.
Some of the competitors in the immunoassay instruments market are Beckman Coulter, Inc., F. Hoffman-La Roche, Ltd., Thermo Fisher Scientific, Ortho Clinical Diagnostics, BioMerieux, Inc., Abbott Laboratories, Sysmex Corporation, DiaSorin S.p.A., Siemens Healthcare, and Merck Millipore Corporation.

Contact:
Mr. Kundan Kumar
Manager – Client Partner
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +18887787886 (USA/Canada)
Email: enquiry@psmarketresearch.com

Connect with us: LinkedIn | Twitter | Google + | Facebook

Comments

Popular posts from this blog

How is Booming Life Sciences Sector Contributing to Growth of Saudi Microbiology Cell Culture Market?

Government and International Organizations Investing Heavily in Synthetic Biology

How is Increasing Focus on Personalized Medicine Driving Cancer/Tumor Profiling Market?